This is a $45,162,200.00 definitive, firm-fixed price contract awarded to Coherus Biosciences, Inc. by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency. The contract is for PEGFILGRASTIM 6MG/.06ML (INJ, SOLN, SYR OR AUTOINJECTOR) and VMI, with a period of performance through March 18, 2030. The contract does not have a set-aside designation. As a provider of biopharmaceutical products, Coherus Biosciences, Inc. will deliver the specified injectable solution and associated vaccine management inventory under this award.
Generated 3/20/25, 9:57 AM